<DOC>
	<DOCNO>NCT01721382</DOCNO>
	<brief_summary>This pilot study conduct adolescent cystic fibrosis ( CF ) without diabetes abnormal glucose tolerance , assess effect sitagliptin glucose regulation . An oral glucose tolerance test ( OGTT ) mix meal tolerance test ( MMTT ) , perform baseline ~4 week treatment study drug . We also look blood sugar throughout day use continuous glucose monitor ( CGM ) time MMTT/OGTT perform . Several hormone may affect way body regulate blood sugar measure blood OGTT MMTT do . We assess effect medicine blood sugar ( use CGM ) effect medicine hormone measure OGTT MMTT .</brief_summary>
	<brief_title>Treatment Dysglycemia Using Sitagliptin Adolescents With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients CF 13 &lt; 21 yrs old Known impaired indeterminate glucose tolerance ( base prior OGTT ) No history CFRD Insulin use last two month Acute pulmonary exacerbation / oral corticosteroid use last 6 week History pancreatitis last 12 month Skin rash condition may affect CGM placement wear Pregnancy intent become pregnant Patients growth hormone therapy Renal insufficiency creatinine clearance &lt; 50 ml/min ( base Schwartz formula )</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>CF</keyword>
	<keyword>CFRD</keyword>
	<keyword>sitagliptin</keyword>
	<keyword>incretins</keyword>
	<keyword>GLP1</keyword>
	<keyword>GIP</keyword>
	<keyword>beta cell function</keyword>
	<keyword>adolescent</keyword>
</DOC>